Koi Therapeutics

Koi Therapeutics is a private biotherapeutics company focused on aesthetics and anti-aging applications, particularly prescription dermatology. The company was created within Turret Capital Management to develop a family of topically acting proprietary small molecule therapeutics licensed through a strategic partnership with Or-Genix Therapeutics. Publicly available information indicates its initial development focus was prescription aesthetic dermatology and products intended to address mechanisms associated with aging skin. Koi Therapeutics appears to operate as a Turret Capital subsidiary or portfolio company rather than as a standalone public company. The company has had limited recent public disclosure, so its pipeline and operating status beyond early development remain sparsely documented.